Highlights from the 13th St Gallen International Breast Cancer Conference 2013. Access to innovation for patients with breast cancer: how to speed it up?

Ecancermedicalscience · 2013 · PMC3622446 · PMID 23589728

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The PHARE trial (6 versus 12 months of trastuzumab) showed a trend favouring one year of treatment but was not fully conclusive.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.